Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 201 | KIO | KKR INCOME OPPORTUNITIES FD | Financial Services | 56,409.0 | $654K | 0.18% | NEW | — | $11.59 | -4.2% |
| 202 | KALV | KALVISTA PHARMACEUTICALS INC | Healthcare | 40,414.0 | $653K | 0.18% | NEW | — | $16.15 | +65.5% |
| 203 | — | BEONE MEDICINES LTD | — | 2,141.0 | $650K | 0.18% | NEW | — | $303.81 | — |
| 204 | TGTX | TG THERAPEUTICS INC | Healthcare | 21,799.0 | $650K | 0.18% | NEW | — | $29.81 | +32.5% |
| 205 | ARWR | ARROWHEAD PHARMACEUTICALS IN | Healthcare | 9,749.0 | $647K | 0.18% | NEW | — | $66.39 | +11.4% |
| 206 | IMCR | IMMUNOCORE HLDGS PLC | Healthcare | 18,569.0 | $645K | 0.17% | NEW | — | $34.71 | -19.2% |
| 207 | RYTM | RHYTHM PHARMACEUTICALS INC | Healthcare | 6,017.0 | $644K | 0.17% | NEW | — | $107.04 | -15.4% |
| 208 | FDUS | FIDUS INVT CORP | Financial Services | 33,322.0 | $643K | 0.17% | NEW | — | $19.30 | -2.6% |
| 209 | ARDX | ARDELYX INC | Healthcare | 110,048.0 | $642K | 0.17% | NEW | — | $5.83 | +4.8% |
| 210 | BGT | BLACKROCK FLOATING RATE INC | Financial Services | 56,588.0 | $641K | 0.17% | NEW | — | $11.33 | -4.1% |
| 211 | NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | 4,472.0 | $634K | 0.17% | NEW | — | $141.83 | +11.7% |
| 212 | CRSP | CRISPR THERAPEUTICS AG | Healthcare | 12,056.0 | $632K | 0.17% | NEW | — | $52.44 | -7.7% |
| 213 | HRMY | HARMONY BIOSCIENCES HLDGS IN | Healthcare | 16,869.0 | $631K | 0.17% | NEW | — | $37.42 | -19.6% |
| 214 | HTGC | HERCULES CAPITAL INC | Financial Services | 33,518.0 | $631K | 0.17% | NEW | — | $18.82 | -17.5% |
| 215 | ADMA | ADMA BIOLOGICS INC | Healthcare | 34,551.0 | $630K | 0.17% | NEW | — | $18.24 | -54.1% |
| 216 | CRNX | CRINETICS PHARMACEUTICALS IN | Healthcare | 13,535.0 | $630K | 0.17% | NEW | — | $46.55 | -21.0% |
| 217 | GBDC | GOLUB CAP BDC INC | Financial Services | 45,915.0 | $623K | 0.17% | NEW | — | $13.57 | -3.8% |
| 218 | INSM | INSMED INC | Healthcare | 3,468.0 | $604K | 0.16% | NEW | — | $174.04 | -37.3% |
| 219 | LENZ | LENZ THERAPEUTICS INC | Healthcare | 37,674.0 | $603K | 0.16% | NEW | — | $16.00 | -56.9% |
| 220 | EVF | EATON VANCE SR INCOME TR | Financial Services | 114,242.0 | $602K | 0.16% | NEW | — | $5.27 | -6.1% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
25.9%
Financial Services
25.7%
Technology
17.4%
Industrials
10.0%
Consumer Cyclical
7.5%
Communication Services
4.3%
Energy
2.6%
Real Estate
2.5%
Consumer Defensive
1.8%
Basic Materials
1.5%